Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

427
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
427
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

537
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
537
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

521
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
521
Varicose Veins II: Diagnostic Studies and Interprofessional Care01:26

Varicose Veins II: Diagnostic Studies and Interprofessional Care

284
Varicose veins, or varicosities, develop when the valves in the veins, which control blood flow, weaken or damage. It causes blood to pool and the veins to enlarge. Understanding the clinical manifestations, diagnostic approaches, and management options for varicose veins is crucial for effective treatment and relief.Clinical manifestationsClinical manifestations of varicose veins include a heavy, achy feeling or pain after prolonged standing or sitting. This discomfort can often be relieved by...
284
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

616
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
616
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

547
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
547

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Modeling and validating of oxygen transport in wave bioreactors: optimized experimental mass transfer method and novel Lattice-Boltzmann CFD approach.

Frontiers in bioengineering and biotechnology·2026
Same author

Comparative analysis of cryoballoon versus radiofrequency catheter ablation in atrial fibrillation patients with impaired left ventricular ejection fraction.

International journal of cardiology. Heart & vasculature·2025
Same author

4D deep learning for real-time volumetric optical coherence elastography.

International journal of computer assisted radiology and surgery·2020
Same author

Transcatheter aortic valve implantation in nonagenarians: insights from the German Aortic Valve Registry (GARY).

Clinical research in cardiology : official journal of the German Cardiac Society·2020
Same author

[New ESC guidelines 2019 for the treatment of supraventricular tachycardia].

Herz·2019
Same author

[Evaluation of mitral regurgitation : How much quantification do we need?]

Herz·2019

Related Experiment Video

Updated: Mar 25, 2026

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement
08:50

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement

Published on: March 26, 2018

12.4K

[Future interventional procedures for valve diseases].

T Thielsen1, C Frerker2, T Schmidt2

  • 1Abteilung für Kardiologie, II. Medizinische Klinik, Asklepios Klinik St. Georg, Lohmühlenstr. 5, 20099, Hamburg, Deutschland. t.thielsen@asklepios.com.

Der Internist
|February 25, 2016
PubMed
Summary
This summary is machine-generated.

Percutaneous valve therapies offer new treatment options for patients with valvular heart disease. These minimally invasive procedures, including aortic and mitral valve treatments, are now standard, with tricuspid valve options under investigation.

Keywords:
Catheter interventionMitral valvePercutaneous treatmentTranscatheter aortic valve implantationTricuspid valve

More Related Videos

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels
08:12

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels

Published on: May 26, 2023

2.7K
A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
08:31

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair

Published on: October 16, 2021

4.6K

Related Experiment Videos

Last Updated: Mar 25, 2026

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement
08:50

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement

Published on: March 26, 2018

12.4K
Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels
08:12

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels

Published on: May 26, 2023

2.7K
A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
08:31

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair

Published on: October 16, 2021

4.6K

Area of Science:

  • Interventional Cardiology
  • Cardiovascular Medicine

Background:

  • Percutaneous valve therapies have emerged as a significant innovation in interventional cardiology over the last decade.
  • These minimally invasive approaches address valvular heart disease, expanding treatment possibilities.

Purpose of the Study:

  • To provide a comprehensive overview of existing and emerging percutaneous therapeutic strategies for valvular heart disease.
  • To highlight the advancements and future directions in the field.

Main Methods:

  • A retrospective and prospective literature search was conducted.
  • Key findings from relevant studies were synthesized and summarized.

Main Results:

  • Percutaneous treatment for aortic and mitral valve diseases has become a standard therapeutic approach.
  • Patients previously deemed inoperable can now benefit from these less invasive interventions.

Conclusions:

  • Percutaneous valve therapies have revolutionized the management of valvular heart disease.
  • Promising results are emerging for percutaneous interventions on the tricuspid valve, indicating a rapidly evolving field.